Explore more publications!

Myanmar Healthcare Monthly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Myanmar Healthcare Monthly.

Press releases published on April 20, 2026

Moonbird Claims Evaluated: Guided Breathing Therapy Device for Meditation-Like Calming Benefits for Relaxation & Sleep Support
Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定,并通过 IND 审评
Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee
Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy
AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat
MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction
BastionGPT Named Top AI Platform for Clinical Psychology Report Writing
Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering
Spectral AI Announces Annual Meeting of Stockholders
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Regeneron Announces Investor Conference Presentations
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
Amwell® to report first quarter 2026 operating results
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions